News
A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.
Dr Ben Bickman told DailyMail.com that people should be weary of the outfall that will come with weight loss medications and ...
Semaglutide use associated with increased risk for NAION at the 2-, 3-, and 4-year time point from the index date.
Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less ...
A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...
As the obesity rate among people with type 1 diabetes rises, patients are taking popular weight loss drugs like Ozempic—and ...
In November, President Biden set out to change that with a new rule that would drastically expand access to this type of ...
Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.
Emergency room visits attributed to popular weight loss drugs such as Ozempic and Wegovy remain quite rare overall, but do ...
As demand soared for weight-loss drugs, price signals worked.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results